Cannabinoid Hyperemesis Syndrome (CHS) is an uncommon but serious condition found in a small portion of regular, long-term cannabis users. CHS was only first formally described by researchers in 2004 and is still not widely known about. This syndrome typically presents as chronic gastrointestinal symptoms highlighted by intense bouts of vomiting and abdominal pain. These symptoms can be severe and can last for hours or days and frequently recur every couple of months. Cases of CHS are on the rise and it still isn’t clear why some heavy cannabis users get the syndrome, but others don't.

The Farmacy Cannabis Lecture Series is proud to host Dr. Codi Peterson, Pharm.D. M.S for a presentation on what researchers know about CHS and what you can do to treat and prevent it. Dr. Peterson is a practicing pharmacist, has a Master's degree in cannabis science, and the Chief Science Officer at The Cannigma, a fact-based cannabis education platform.
  • 1616035343-3c5685006b38b523
    Farmacy Cannabis Lecture Series
  • 1660596570-6d18aa60901f6803
    Dr. Codi Peterson, Pharm.D. M.S
    Cannigma Chief Science Officer
    Codi Peterson, Pharm.D. M.S. is The Cannigma's Chief Science Officer. He is a practicing pharmacist with a passion for cannabis-based medicine. Given his diverse pediatric pharmacy experience and knack for educating, he tries to share his knowledge whenever possible. Building on his experience teaching healthcare professionals about pharmacology and pharmacotherapy, he aims to educate as many as possible about the medicinal potential of cannabis.